Ad-HGF Treatment for Myocardial Infarction
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT02844283
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 1/2
- Enrolled
- 100 participants
- Registry
-
NCT02844283
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- Not reported
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT02844283. Randomized; quadruple masking; primary purpose treatment. Start 2016-11 (registry gives no type); primary completion 2018-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ad-HGF Treatment for Myocardial Infarction
- Condition
- Myocardial Infarction
- Intervention (Drug)
- Ad-HGF
- Intervention (Other)
- 0.9% NaCl
- Lead sponsor
- The First Affiliated Hospital with Nanjing Medical University
Record details
- Record id
cardio:ct-nct02844283- Content hash
dcb1dd88c4ce2e16b49a7aef121f0160410c7865f5e45022e8237f27aac9039d